Immix Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	79.25	93.93	17.68	17.51	13.44	17.64
Short-Term Investments	11.33	6.48	-	-	-	-
Cash & Short-Term Investments	90.58	100.41	17.68	17.51	13.44	17.64
Cash Growth	468.93%	467.86%	0.98%	30.31%	-23.85%	4411.67%
Other Receivables	-	-	1.97	1.17	0.26	0.03
Total Trade Receivables	-	-	1.97	1.17	0.26	0.03
Other Current Assets	1.7	0.83	0.54	1.11	1.21	0.52
Total Current Assets	92.27	101.24	20.2	19.79	14.9	18.19
Net Property, Plant & Equipment	3.36	3.49	2.73	0.05	0	0.01
Other Long-Term Assets	0.19	0.11	0.02	0.09	0.01	-
Total Assets	95.82	104.84	22.95	19.93	14.91	18.19
Accounts Payable	10.41	9.97	8.62	3.72	1.27	0.14
Accrued Expenses	-	-	-	-	-	0.01
Short-Term Debt	-	-	-	-	-	0.05
Current Portion of Leases	0.13	0.14	0.07	-	-	-
Total Current Liabilities	10.54	10.11	8.69	3.72	1.27	0.2
Long-Term Leases	0.91	0.93	1.01	-	-	-
Other Long-Term Liabilities	-	-	-	-	0.48	-
Total Long-Term Liabilities	0.91	0.93	1.01	-	0.48	-
Total Liabilities	11.45	11.04	9.7	3.72	1.75	0.2
Common Stock	0.01	0.01	0	0	0	0
Treasury Stock	-0.1	-0.1	-0.1	-0.1	-0.1	-
Additional Paid-in Capital	198.9	198.29	88.37	69.78	51.16	47.62
Accumulated Other Comprehensive Income	0.11	0.06	-0	0.13	0.09	0.13
Retained Earnings	-114.55	-104.46	-75.02	-53.41	-37.99	-29.76
Total Common Shareholders' Equity	84.36	93.8	13.25	16.41	13.16	17.99
Minority Interest	-	-	-	-0.2	-	-
Shareholders' Equity	84.36	93.8	13.25	16.2	13.16	17.99
Total Liabilities & Equity	95.82	104.84	22.95	19.93	14.91	18.19
Total Debt	1.04	1.07	1.07	0	0	0.05
Net Cash (Debt)	89.54	99.34	16.61	17.51	13.44	17.59
Net Cash Growth	-9.86%	498.15%	-5.16%	30.31%	-23.63%	-
Net Cash Per Share	2.27	3.01	0.59	1.01	0.97	4.79
Book Value	84.36	93.8	13.25	16.41	13.16	17.99
Book Value Per Share	2.14	2.85	0.47	0.95	0.95	4.90
Tangible Book Value	84.36	93.8	13.25	16.41	13.16	17.99
Tangible Book Value Per Share	2.14	2.85	0.47	0.95	0.95	4.90

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q